<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">Colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) remains one of the major public health problems throughout the world </plain></SENT>
<SENT sid="1" pm="."><plain>Originally depicted as a multi-step dynamical disease, <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> develops slowly over several years and progresses through cytologically distinct benign and <z:e sem="disease" ids="C0599849" disease_type="Neoplastic Process" abbrv="">malignant states</z:e>, from single crypt lesions through <z:mpath ids='MPATH_270'>adenoma</z:mpath>, to malignant <z:mp ids='MP_0002038'>carcinoma</z:mp> with the potential for invasion and <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>Moving from histological observations since a long time, it has been recognized that <z:mp ids='MP_0001845'>inflammation</z:mp> and immunity actively participate in the pathogenesis, surveillance and progression of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>The advent of immunohistochemical techniques and of animal models has improved our understanding of the immune dynamical system in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>It is well known that immune cells have variable behavior controlled by complex interactions in the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> microenvironment </plain></SENT>
<SENT sid="5" pm="."><plain>Advances in immunology and molecular biology have shown that <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> is immunogenic and that host immune responses influence survival </plain></SENT>
<SENT sid="6" pm="."><plain>Several lines of evidence support the concept that <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> stromal cells, are not merely a scaffold, but rather they influence growth, survival, and invasiveness of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> cells, dynamically contributing to the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> microenvironment, together with immune cells </plain></SENT>
<SENT sid="7" pm="."><plain>Different types of immune cells infiltrate <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>, comprising cells of both the innate and adaptive immune system </plain></SENT>
<SENT sid="8" pm="."><plain>A relevant issue is to unravel the discrepancy between the inhibitory effects on <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> growth exerted by the local immune response and the promoting effects on <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> proliferation, invasion, and dissemination induced by some types of inflammatory cells </plain></SENT>
<SENT sid="9" pm="."><plain>Here, we sought to discuss the role played by innate and adaptive immune system in the local progression and <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>, and the prognostic information that we can currently understand and exploit </plain></SENT>
</text></document>